HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ji Cao Selected Research

N- (2- (1H- indazol- 3- yl)- 1H- pyrrole(3,2- b)pyridin- 5- yl)- 4- chloro- N- methylbenzamide

12/2010SMT-A07, a 3-(Indol-2-yl) indazole derivative, induces apoptosis of leukemia cells in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ji Cao Research Topics

Disease

72Neoplasms (Cancer)
12/2022 - 03/2003
24Hepatocellular Carcinoma (Hepatoma)
12/2022 - 03/2003
15Carcinogenesis
03/2022 - 09/2007
15Neoplasm Metastasis (Metastasis)
03/2022 - 07/2004
10Inflammation (Inflammations)
05/2022 - 01/2017
10Infections
04/2022 - 03/2005
9Hypoxia (Hypoxemia)
01/2021 - 11/2010
7Liver Neoplasms (Liver Cancer)
11/2020 - 06/2008
6Lung Neoplasms (Lung Cancer)
01/2022 - 06/2007
5Osteosarcoma (Osteogenic Sarcoma)
01/2020 - 01/2017
4Parkinson Disease (Parkinson's Disease)
07/2021 - 02/2015
3Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 01/2019
3Triple Negative Breast Neoplasms
01/2022 - 01/2020
3Leukemia
10/2021 - 12/2010
3Prostatic Neoplasms (Prostate Cancer)
04/2021 - 01/2007
3Breast Neoplasms (Breast Cancer)
01/2020 - 07/2005
3Thrombosis (Thrombus)
02/2016 - 07/2004
2Heart Failure
06/2022 - 01/2022
2Atherosclerosis
05/2022 - 03/2022
2Acute Promyelocytic Leukemia
01/2022 - 10/2021
2Lipid Metabolism Disorders (Metabolism Disorders, Lipid)
11/2021 - 01/2020
2Non-alcoholic Fatty Liver Disease
11/2021 - 10/2020
2Fibrosis (Cirrhosis)
11/2021 - 02/2005
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2021 - 05/2014
2Colitis
01/2021 - 01/2020
2Mitochondrial Diseases (Mitochondrial Disease)
10/2020 - 01/2020
2Obesity
10/2020 - 01/2020
2Ovarian Neoplasms (Ovarian Cancer)
08/2020 - 05/2019
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 06/2007
2Testicular Neoplasms (Testicular Cancer)
03/2005 - 03/2003

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
05/2022 - 05/2007
12Pharmaceutical PreparationsIBA
07/2022 - 01/2009
11Biological ProductsIBA
10/2021 - 06/2008
9Messenger RNA (mRNA)IBA
02/2016 - 07/2004
8Dehydroepiandrosterone (DHEA)IBA
04/2022 - 01/2019
7DNA (Deoxyribonucleic Acid)IBA
10/2021 - 06/2007
5Reactive Oxygen Species (Oxygen Radicals)IBA
10/2021 - 06/2014
5Lysine (L-Lysine)FDA Link
10/2021 - 01/2019
5Aflatoxin B1 (Aflatoxin B)IBA
10/2007 - 02/2004
4Transcription Factors (Transcription Factor)IBA
03/2022 - 11/2010
4p38 Mitogen-Activated Protein KinasesIBA
10/2020 - 10/2019
3Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
06/2022 - 01/2022
3LipidsIBA
03/2022 - 01/2020
3Protein Kinases (Protein Kinase)IBA
01/2022 - 01/2020
3Tretinoin (Retinoic Acid)FDA LinkGeneric
10/2021 - 01/2017
3Therapeutic UsesIBA
10/2021 - 10/2014
3Ligases (Synthetase)IBA
02/2021 - 01/2021
3Proteasome Endopeptidase Complex (Proteasome)IBA
02/2021 - 01/2017
3UbiquitinIBA
01/2021 - 01/2018
3Interleukin-6 (Interleukin 6)IBA
01/2021 - 10/2014
3AntioxidantsIBA
01/2021 - 06/2008
3Sirtuin 2IBA
11/2020 - 01/2019
3EnzymesIBA
11/2020 - 02/2013
3SirtuinsIBA
11/2020 - 01/2017
3Small Interfering RNA (siRNA)IBA
03/2020 - 09/2010
3Aldo-Keto ReductasesIBA
01/2020 - 01/2017
3FenretinideIBA
01/2017 - 11/2010
3alpha-Fetoproteins (alpha-Fetoprotein)IBA
03/2005 - 07/2004
2Fatty Acid-Binding ProteinsIBA
12/2022 - 04/2012
2retinamideIBA
07/2022 - 09/2009
2Calcium-Calmodulin-Dependent Protein KinasesIBA
06/2022 - 01/2022
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
03/2022 - 10/2020
2Adenosine Triphosphate (ATP)IBA
01/2022 - 01/2020
2Oncogene Proteins (Oncogene Protein)IBA
01/2022 - 02/2021
2Monoclonal AntibodiesIBA
01/2022 - 01/2021
2Palmitic Acid (Hexadecanoic Acid)IBA
11/2021 - 01/2020
2Estrogens (Estrogen)FDA Link
11/2021 - 07/2005
2Phosphotransferases (Kinase)IBA
10/2021 - 02/2021
2Chloroquine (Aralen)FDA LinkGeneric
10/2021 - 11/2010
2AMP-Activated Protein KinasesIBA
10/2021 - 10/2020
2Mechanistic Target of Rapamycin Complex 1IBA
10/2021 - 11/2010
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
10/2021 - 11/2010
2InflammasomesIBA
01/2021 - 01/2020
2LipopolysaccharidesIBA
01/2021 - 01/2019
2CytokinesIBA
01/2021 - 01/2020
2Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2021 - 11/2015
2Malondialdehyde (Propanedial)IBA
01/2021 - 01/2020
2IronIBA
01/2021 - 01/2020
2rho Guanine Nucleotide Dissociation Inhibitor betaIBA
01/2021 - 11/2015
2Diethylnitrosamine (N-Nitrosodiethylamine)IBA
11/2020 - 01/2020
2Deubiquitinating EnzymesIBA
01/2020 - 01/2020
2Doxorubicin (Adriamycin)FDA LinkGeneric
02/2019 - 01/2017
2Bortezomib (Velcade)FDA Link
01/2018 - 01/2017
2conteltinibIBA
01/2018 - 12/2016
2VaccinesIBA
01/2018 - 12/2016
2Drug CombinationsIBA
01/2017 - 12/2016
2lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
12/2016 - 06/2007
2Etoposide (VP 16)FDA LinkGeneric
05/2015 - 10/2011
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2015 - 12/2011
2Hypoxia-Inducible Factor 1IBA
05/2014 - 11/2010
2Tirapazamine (SR 4233)IBA
03/2014 - 11/2010
2Type II DNA Topoisomerases (Topoisomerase II)IBA
02/2013 - 10/2011
2PeroxiredoxinsIBA
06/2008 - 05/2007
2beta CateninIBA
10/2007 - 10/2007
2SCP 1IBA
03/2005 - 03/2003
2AntigensIBA
03/2005 - 03/2003
2ErbB Receptors (EGF Receptor)IBA
02/2005 - 07/2004

Therapy/Procedure

29Therapeutics
07/2022 - 07/2009
9Drug Therapy (Chemotherapy)
03/2022 - 06/2007
2Neoadjuvant Therapy
10/2021 - 01/2020